These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19896806)

  • 1. Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations.
    Burkhardt O; Kumar V; Schmidt S; Kielstein JT; Welte T; Derendorf H
    Int J Antimicrob Agents; 2010 Jan; 35(1):96-7. PubMed ID: 19896806
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacokinetics of once-daily dosing of ertapenem in critically ill patients with severe sepsis.
    Brink AJ; Richards GA; Schillack V; Kiem S; Schentag J
    Int J Antimicrob Agents; 2009 May; 33(5):432-6. PubMed ID: 19091521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring of beta-lactams for critically ill patients: unwarranted or essential?
    Roberts JA; Hope WW; Lipman J
    Int J Antimicrob Agents; 2010 May; 35(5):419-20. PubMed ID: 20189777
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of beta-lactam regimens for the treatment of gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics.
    Burgess DS; Frei CR
    J Antimicrob Chemother; 2005 Nov; 56(5):893-8. PubMed ID: 16162664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections.
    Verdier MC; Seguin P; Le Touvet B; Cady A; Mallédant Y; Tribut O
    J Antimicrob Chemother; 2011 Aug; 66(8):1934-6. PubMed ID: 21632578
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacokinetics of free ertapenem in critically ill septic patients: intermittent versus continuous infusion.
    Breilh D; Fleureau C; Gordien JB; Joanes-Boyau O; Texier-Maugein J; Rapaport S; Boselli E; Janvier G; Saux MC
    Minerva Anestesiol; 2011 Nov; 77(11):1058-62. PubMed ID: 21597443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution.
    Roberts JA; Kirkpatrick CM; Roberts MS; Robertson TA; Dalley AJ; Lipman J
    J Antimicrob Chemother; 2009 Jul; 64(1):142-50. PubMed ID: 19398460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ertapenem in critically ill patients with early-onset ventilator-associated pneumonia: pharmacokinetics with special consideration of free-drug concentration.
    Burkhardt O; Kumar V; Katterwe D; Majcher-Peszynska J; Drewelow B; Derendorf H; Welte T
    J Antimicrob Chemother; 2007 Feb; 59(2):277-84. PubMed ID: 17185298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing antibiotic pharmacodynamics in hospital-acquired and ventilator-acquired bacterial pneumonia.
    Housman ST; Kuti JL; Nicolau DP
    Clin Chest Med; 2011 Sep; 32(3):439-50. PubMed ID: 21867814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of carbapenems in the treatment of severe nosocomial respiratory tract infections.
    Joseph J; Rodvold KA
    Expert Opin Pharmacother; 2008 Mar; 9(4):561-75. PubMed ID: 18312158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the parenteral antibiotic Ertapenem as short term prophylaxis in bariatric surgery: a pharmaco-kinetic-pharmacodynamic study in class III obese female patients.
    Borracci T; Adembri C; Accetta G; Berti J; Cappellini I; Lucchese M; Biggeri A; De Gaudio AR; Novelli A
    Minerva Anestesiol; 2014 Sep; 80(9):1005-11. PubMed ID: 24476845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between augmented renal clearance, antibiotic exposure and clinical outcome in critically ill septic patients receiving high doses of β-lactams administered by continuous infusion: a prospective observational study.
    Carrié C; Petit L; d'Houdain N; Sauvage N; Cottenceau V; Lafitte M; Foumenteze C; Hisz Q; Menu D; Legeron R; Breilh D; Sztark F
    Int J Antimicrob Agents; 2018 Mar; 51(3):443-449. PubMed ID: 29180280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakpoints for extended-spectrum beta-lactamase-producing Enterobacteriacae: pharmacokinetic/pharmacodynamic considerations.
    MacGowan A
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():166-8. PubMed ID: 18154541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is the use of vancomycin doses of at least 1 g every 8 hours the only way to achieve optimal trough levels in critically ill trauma patients with pneumonia and normal renal function?
    Pea F; Furlanut M; Viale P
    J Trauma; 2010 Mar; 68(3):748-9. PubMed ID: 20220431
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of ertapenem in outpatients with complicated urinary tract infections.
    Zhou J; Sulaiman Z; Llorin RM; Hee KH; Lee LS; Lye DC; Fisher DA; Tam VH
    J Antimicrob Chemother; 2014 Sep; 69(9):2517-21. PubMed ID: 24797063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ertapenem peritoneal fluid concentrations in adult surgical patients.
    Arrigucci S; Garcea A; Fallani S; Cassetta MI; Canonico G; Tonelli F; Mazzei T; Novelli A
    Int J Antimicrob Agents; 2009 Apr; 33(4):371-3. PubMed ID: 19097758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing β-lactams treatment in critically-ill patients using pharmacokinetics/pharmacodynamics targets: are first conventional doses effective?
    Delattre IK; Taccone FS; Jacobs F; Hites M; Dugernier T; Spapen H; Laterre PF; Wallemacq PE; Van Bambeke F; Tulkens PM
    Expert Rev Anti Infect Ther; 2017 Jul; 15(7):677-688. PubMed ID: 28571493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of ertapenem in critically ill patients receiving continuous venovenous hemodialysis or hemodiafiltration.
    Eyler RF; Vilay AM; Nader AM; Heung M; Pleva M; Sowinski KM; DePestel DD; Sörgel F; Kinzig M; Mueller BA
    Antimicrob Agents Chemother; 2014; 58(3):1320-6. PubMed ID: 24323468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue pharmacokinetics of ertapenem at steady-state in diabetic patients with leg infections.
    Sauermann R; Burian B; Burian A; Jäger W; Höferl M; Stella A; Theurer S; Riedl M; Zeitlinger M
    J Antimicrob Chemother; 2013 Apr; 68(4):895-9. PubMed ID: 23212112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.